- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00713752
Establishing Normal Values for Neuropsychological Testing in HIV-negative Thais
Study Overview
Status
Conditions
Detailed Description
The Southeast Asia Research Collaboration with Hawaii (SEARCH) operates or collaborates on several neuroAIDS research protocols. To allow accurate interpretation of neuropsychological data, normative data that are obtained in a similar population are needed. Currently, there are limited such data available for this purpose.
The SEARCH 001 study evaluated the neurocognitive changes before and after highly active antiretroviral therapy in 30 HIV positive subjects and has also enrolled 230/300 proposed HIV-negative controls for this purpose. Normative data tables typically require many more individuals so that age and education strata can be established. We now propose to enroll up to 1000 HIV-seronegative individuals for this purpose.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Bangkok, Thailand, 10330
- SEARCH Thailand
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Age 20-69
- Male or female
- Negative HIV antibody at screening
- Have the ability to understand the study and signed the informed consent form
Exclusion Criteria:
- Head injury with loss of consciousness greater than 1 hour
- Current or past illicit drug use or positive drug screen for amphetamine, methamphetamines, cocaine, marijuana, or narcotics
- Severe illness within 30 days prior to entry
- Current or recent fevers or meningeal signs.
- History of pre-existing neurologic disease to include stroke, multiple sclerosis or autoimmune disease.
- active major depression will be excluded as well - patients with past depression that is controlled and patients with or minor depressive symptoms will be allowed to enroll.
- Known learning disability including dyslexia
- Confusion or other signs and symptoms of metabolic encephalopathy or delirium
- Focal neurological deficit on examination
- Examining physician's concern that participant may not be able to complete visit requirements.
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
To establish normal values for neuropsychological testing in HIV negative Thais stratified by age (1 decade) and education
Time Frame: July 31, 2014
|
July 31, 2014
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
To estimate the learning effect on these test at 6 months and 12 months.
Time Frame: July 31, 2014
|
July 31, 2014
|
Collaborators and Investigators
Investigators
- Principal Investigator: Victor - Valcour, M.D., University of Hawaii
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- SEARCH002
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.